HuGE Literature Finder
Records
1
-
13
| Real-World Analysis of Off-Label Use of Molecularly Targeted Therapy in a Large Academic Medical Center Cohort. JCO precision oncology 2022 1 6 e2100232. Upadhyay Vivek A, Johnson Bruce E, Landman Adam B, Hassett Michael |
| Pan-Cancer Efficacy of Vemurafenib in BRAF-Mutant Non-Melanoma Cancers. Cancer discovery 2020 Feb . Subbiah Vivek, Puzanov Igor, Blay Jean-Yves, Chau Ian, Lockhart Albert Craig, Raje Noopur S, Wolf Juergen, Baselga Jose, Meric-Bernstam Funda, Roszik Jason, Diamond Eli L, Riely Gregory J, Sherman Eric J, Riehl Todd, Pitcher Bethany, Hyman David |
| Mucinous intrahepatic cholangiocarcinoma: a distinct variant. Human pathology 2018 Apr . Chi Zhikai, Bhalla Amarpreet, Saeed Omer, Cheng Liang, Curless Kendra, Wang Hanlin L, Patil Deepa T, Lin Jingm |
| Mutation analysis and copy number changes of KRAS and BRAF genes in Taiwanese cases of biliary tract cholangiocarcinoma. Journal of the Formosan Medical Association = Taiwan yi zhi 2016 Oct . Huang Wen-Chih, Tsai Chien-Chen, Chan Chih-Chi |
| BRAF V600E mutation in biliary proliferations associated with a -antitrypsin deficiency. Histopathology 2016 Sep . Angkathunyakul Napat, Rosini Francesca, Heaton Nigel, Foskett Pierre, Quaglia Alber |
| Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations. The New England journal of medicine 2015 Aug 373 (8): 726-36. Hyman David M, Puzanov Igor, Subbiah Vivek, Faris Jason E, Chau Ian, Blay Jean-Yves, Wolf Jürgen, Raje Noopur S, Diamond Eli L, Hollebecque Antoine, Gervais Radj, Elez-Fernandez Maria Elena, Italiano Antoine, Hofheinz Ralf-Dieter, Hidalgo Manuel, Chan Emily, Schuler Martin, Lasserre Susan Frances, Makrutzki Martina, Sirzen Florin, Veronese Maria Luisa, Tabernero Josep, Baselga Jo |
| Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets. Annals of surgical oncology 2014 Nov 21 (12): 3827-34. Zhu Andrew X, Borger Darrell R, Kim Yuhree, Cosgrove David, Ejaz Aslam, Alexandrescu Sorin, Groeschl Ryan Thomas, Deshpande Vikram, Lindberg James M, Ferrone Cristina, Sempoux Christine, Yau Thomas, Poon Ronnie, Popescu Irinel, Bauer Todd W, Gamblin T Clark, Gigot Jean Francois, Anders Robert A, Pawlik Timothy |
| Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan. Journal of gastroenterology and hepatology 2014 May 29 (5): 1119-25. Chang Yu-Ting, Chang Ming-Chu, Huang Kai-Wen, Tung Chien-Chih, Hsu Chiun, Wong Jau-M |
| The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome. Human pathology 2013 Dec 44 (12): 2768-73. Robertson Scott, Hyder Omar, Dodson Rebecca, Nayar Suresh K, Poling Justin, Beierl Katie, Eshleman James R, Lin Ming-Tseh, Pawlik Timothy M, Anders Robert |
| Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions. Human pathology 2013 Feb . Voss JS, Holtegaard LM, Kerr SE, Fritcher EG, Roberts LR, Gores GJ, Zhang J, Highsmith WE, Halling KC, Kipp BR |
| Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 2013 Jan . Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, Tabak B, Peix J, Sole M, Tovar V, Alsinet C, Cornella H, Klotzle B, Fan JB, Cotsoglou C, Thung SN, Fuster J, Waxman S, Garcia-Valdecasas JC, Bruix J, Schwartz ME, Beroukhim R, Mazzaferro V, Llovet JM |
| Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. The oncologist 2012 17 (1): 72-9. Borger Darrell R, Tanabe Kenneth K, Fan Kenneth C, Lopez Hector U, Fantin Valeria R, Straley Kimberly S, Schenkein David P, Hezel Aram F, Ancukiewicz Marek, Liebman Hannah M, Kwak Eunice L, Clark Jeffrey W, Ryan David P, Deshpande Vikram, Dias-Santagata Dora, Ellisen Leif W, Zhu Andrew X, Iafrate A Jo |
| KRAS and PIK3CA but not BRAF genes are frequently mutated in Chinese cholangiocarcinoma patients. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2011 Feb 65 (1): 22-6. Xu Rui Feng, Sun Ji Ping, Zhang Shi Rong, Zhu Guan Shan, Li Li Bo, Liao Yu Lin, Xie Jian Ming, Liao Wang J |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: